Integra LifeSciences Reports Third Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Integra LifeSciences (IART) Tops Q3 EPS by 1c, Updates FY Guidance
November 3, 2015 8:03 AM ESTIntegra LifeSciences (NASDAQ: IART) reported Q3 EPS of $0.75, $0.01 better than the analyst estimate of $0.74. Revenue for the quarter came in at $226.4 million versus the consensus estimate of $224.08 million.
Integra LifeSciences sees FY2015 EPS of $3.05-$3.10, versus the consensus of $3.06. Integra LifeSciences sees FY2015... More
